Literature DB >> 10557261

Inhibition of gene expression in human cells through small molecule-RNA interactions.

S Hwang1, N Tamilarasu, K Ryan, I Huq, S Richter, W C Still, T M Rana.   

Abstract

Small molecules that bind their biological receptors with high affinity and selectivity can be isolated from randomized pools of combinatorial libraries. RNA-protein interactions are important in many cellular functions, including transcription, RNA splicing, and translation. One example of such interactions is the mechanism of trans-activation of HIV-1 gene expression that requires the interaction of Tat protein with the trans-activation responsive region (TAR) RNA, a 59-base stem-loop structure located at the 5' end of all nascent HIV-1 transcripts. Here we demonstrate the isolation of small TAR RNA-binding molecules from an encoded combinatorial library. We have made an encoded combinatorial tripeptide library of 24,389 possible members from D-and L-alpha amino acids on TentaGel resin. Using on-bead screening we have identified a small family of mostly heterochiral tripeptides capable of structure-specific binding to the bulge loop of TAR RNA. In vitro binding studies reveal stereospecific discrimination when the best tripeptide ligand is compared with diastereomeric peptide sequences. In addition, the most strongly binding tripeptide was shown to suppress transcriptional activation by Tat protein in human cells with an IC(50) of approximately 50 nM. Our results indicate that tripeptide RNA ligands are cell permeable, nontoxic to cells, and capable of inhibiting expression of specific genes by interfering with RNA-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557261      PMCID: PMC23888          DOI: 10.1073/pnas.96.23.12997

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  A Structural Basis for RNAminus signLigand Interactions.

Authors:  Christine S. Chow; Felicia M. Bogdan
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

Review 2.  Oligonucleotide-directed DNA triple-helix formation: an approach to artificial repressors?

Authors:  L J Maher; B Wold; P B Dervan
Journal:  Antisense Res Dev       Date:  1991

3.  Complex synthetic chemical libraries indexed with molecular tags.

Authors:  M H Ohlmeyer; R N Swanson; L W Dillard; J C Reader; G Asouline; R Kobayashi; M Wigler; W C Still
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

4.  Major groove accessibility of RNA.

Authors:  K M Weeks; D M Crothers
Journal:  Science       Date:  1993-09-17       Impact factor: 47.728

5.  A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.

Authors:  F Hamy; V Brondani; A Flörsheimer; W Stark; M J Blommers; T Klimkait
Journal:  Biochemistry       Date:  1998-04-14       Impact factor: 3.162

6.  Luciferase reporter gene vectors for analysis of promoters and enhancers.

Authors:  S K Nordeen
Journal:  Biotechniques       Date:  1988-05       Impact factor: 1.993

7.  Regulation of gene expression by small molecules.

Authors:  J M Gottesfeld; L Neely; J W Trauger; E E Baird; P B Dervan
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

Review 8.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

9.  Major groove opening at the HIV-1 Tat binding site of TAR RNA evidenced by a rhodium probe.

Authors:  H R Neenhold; T M Rana
Journal:  Biochemistry       Date:  1995-05-16       Impact factor: 3.162

10.  Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists.

Authors:  S N Ho; S H Boyer; S L Schreiber; S J Danishefsky; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more
  21 in total

Review 1.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

2.  Inhibition of translation by RNA-small molecule interactions.

Authors:  Isabelle Harvey; Philippe Garneau; Jerry Pelletier
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

3.  Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative.

Authors:  Sara Richter; Cristina Parolin; Barbara Gatto; Claudia Del Vecchio; Egidio Brocca-Cofano; Arnaldo Fravolini; Giorgio Palù; Manlio Palumbo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

4.  Click dimers to target HIV TAR RNA conformation.

Authors:  Sunil Kumar; Patrick Kellish; W Edward Robinson; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Biochemistry       Date:  2012-03-09       Impact factor: 3.162

5.  A modified fluorescent intercalator displacement assay for RNA ligand discovery.

Authors:  Papa Nii Asare-Okai; Christine S Chow
Journal:  Anal Biochem       Date:  2010-09-21       Impact factor: 3.365

6.  Toward targeting RNA structure: branched peptides as cell-permeable ligands to TAR RNA.

Authors:  David I Bryson; Wenyu Zhang; Patrick M McLendon; Theresa M Reineke; Webster L Santos
Journal:  ACS Chem Biol       Date:  2011-10-28       Impact factor: 5.100

7.  Conformational dynamics of RNA-peptide binding: a molecular dynamics simulation study.

Authors:  Yuguang Mu; Gerhard Stock
Journal:  Biophys J       Date:  2005-10-20       Impact factor: 4.033

8.  Molecular recognition of HIV-1 RNAs with branched peptides.

Authors:  Ashley N Peralta; Yumin Dai; Chringma Sherpa; Stuart F J Le Grice; Webster L Santos
Journal:  Methods Enzymol       Date:  2019-05-15       Impact factor: 1.600

9.  Recognition of HIV TAR RNA by triazole linked neomycin dimers.

Authors:  Sunil Kumar; Dev P Arya
Journal:  Bioorg Med Chem Lett       Date:  2011-06-21       Impact factor: 2.823

10.  Using an emissive uridine analogue for assembling fluorescent HIV-1 TAR constructs.

Authors:  Seergazhi G Srivatsan; Yitzhak Tor
Journal:  Tetrahedron       Date:  2007-04-23       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.